Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole for cardioprotection in coronary artery bypass surgery
ISRCTN30506717Phase 2Completed
- Sponsor
- Canberra Hospital
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of riluzole in cardiac ischemia and coronary arteriosclerosis, sponsored by Canberra Hospital. Started Jul 2010; status: completed.
02
Drugs
riluzole
03
Conditions
cardiac ischemiacoronary arteriosclerosis
Beyond the preview
Go deeper on ISRCTN30506717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN30506717.